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Editorial
S
ince our launch in October 2004, 
PLoS Medicine has published 
a policy and review section 
dedicated to neglected diseases. 
Its focus has been on the chronic 
tropical infections, mostly parasitic 
and bacterial, that burden the world’s 
poorest people and that are also a 
major cause of global poverty. The 
many ways in which these diseases have 
been sidelined are well documented 
[1], and our main aim for the section 
was to help to place these conditions in 
the limelight. So what has the section 
achieved, and where is it heading 
next, particularly now that PLoS has 
launched a journal dedicated to the 
neglected tropical diseases (NTDs; 
http://www.plosntds.org/)?
The 21 articles published to 
date give a broad-ranging overview 
of the landscape of NTDs. Each 
article focused either on the global 
campaign to tackle a speciﬁc disease, 
such as trachoma or Buruli ulcer, or 
on a new strategy for approaching 
neglected diseases in general, 
including innovative ways of designing, 
developing, and funding antiparasitic 
drugs (see Text S1). 
Many of these articles have 
challenged the widespread sense 
of hopelessness surrounding the 
NTDs. Mary Moran’s analysis [2], for 
example, found that 63 neglected-
disease drug projects were under way 
at the end of 2004, three-quarters 
of which are being conducted by 
public–private partnerships, often 
involving multinational or small-scale 
pharmaceutical ﬁrms. As we have 
written before, we are witnessing “a 
new era of hope for the world’s most 
neglected diseases” [3].
The Neglected Diseases section 
has arguably had an impact upon 
the wider global health community, 
for example among policy makers 
and funding agencies. Two articles 
in particular stand out for their 
international inﬂuence. The ﬁrst, by 
David Molyneux, Peter Hotez, and 
Alan Fenwick, presented the case for 
integrating the control of NTDs in 
Africa by scaling up a “rapid-impact 
package” of four antimicrobial drugs 
that have synergistic actions on 
multiple diseases [4]. This package, 
argued the authors, could tackle seven 
NTDs (schistosomiasis, trachoma, 
lymphatic ﬁlariasis, onchocerciasis, 
hookworm, trichuriasis, and ascariasis) 
at an annual cost of only about 
$US0.40 per person. The authors’ 
follow-up article discussed the many 
opportunities for integrating NTD 
control with that of the “big three” 
diseases: HIV, malaria, and tuberculosis 
[5].
The ﬁrst of these two articles led 
to a United Kingdom parliamentary 
question, by Member of Parliament 
Nicholas Soames, about the UK’s 
funding of parasitic diseases [6], while 
the second helped make the case for a 
United Nations mandate to incorporate 
NTD control into its campaign to roll 
back malaria [7]. Both papers laid the 
foundation for the creation of a new 
global nonproﬁt organization, the 
Global Network for Neglected Tropical 
Disease Control (GNNTDC, http://
gnntdc.sabin.org/). And the idea of 
integrated control, laid out in the 
two papers, has gained traction in the 
donor community—the United States 
Agency for International Development, 
for example, awarded a $US100 million 
grant to RTI International to scale up 
integrated control of NTDs in Africa 
[8], while Geneva Global Inc. awarded 
the GNNTDC US$8.9 million to deliver 
the “rapid-impact package” in Rwanda 
and Burundi [9]. 
PLoS Medicine’s Neglected Diseases 
section was also the catalyst for the 
launch of the world’s ﬁrst open-access 
journal speciﬁcally devoted to the 
NTDs. In 2005, the section caught the 
attention of Professor Peter Hotez 
at George Washington University 
and the Sabin Vaccine Institute, who 
proposed to PLoS that we launch 
PLoS Neglected Tropical Diseases. One 
of us (GY) presented the idea at the 
World Health Organization’s (WHO’s) 
“Strategic and technical meeting on 
intensiﬁed control of neglected tropical 
diseases” in Berlin in April 2005 [10], 
which led to the WHO’s Department 
of Neglected Tropical Diseases giving 
the proposal its formal support. The 
momentum continued to build—
several global leaders in NTDs agreed 
to serve on the journal’s editorial 
board, and the Bill & Melinda Gates 
Foundation awarded PLoS a $US1.1 
million grant to cover the journal’s 
launch phase. 
PLoS Neglected Tropical Diseases—
which publishes research, commentary, 
analysis, and reviews on the pathology, 
epidemiology, treatment, control, and 
prevention of the NTDs—launched 
at the end of October 2007. Its arrival 
was heralded in the New York Times 
(November 6,2007) with the headline 
“Shining Light on Diseases Often in 
the Shadows” [11], while an editorial 
in The Lancet about the new journal 
praised the “investment in scaling 
up communication about global 
health” [12]. The journal publishes 
the broadest range of NTDs research 
in a single open-access venue, while 
its Magazine section advocates for 
those who suffer from the plight of 
these tropical infections. Built upon 
an online publishing platform called 
Topaz (see http://www.plos.org/cms/
node/36/), the journal takes advantage 
of the latest “Web 2.0” tools from 
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PLoS, including readers’ annotations, 
discussion threads, and article rankings. 
Its editorial board is well represented 
by developing-world scientists (http://
www.plosntds.org/static/edboard.
action).
The arrival of PLoS’ latest journal 
means that it now makes little sense for 
the PLoS Medicine Neglected Diseases 
section to focus on the NTDs. This 
month’s article, examining the WHO 
strategy to eliminate human African 
trypanosomiasis, therefore marks the 
last time that this section will feature 
a tropical infection [13]. Instead, the 
section will focus on other health 
problems that could be considered 
neglected and that have a signiﬁcant 
global burden. We will ask authors to 
justify in their article, with supporting 
evidence, why they consider the 
problem to be neglected, to outline the 
scale of the problem worldwide, and to 
discuss possible policies and solutions 
for reducing the burden of disease. 
Examples might include reproductive 
and maternal health problems, mental 
illness in low- and middle-income 
countries, road trafﬁc injuries, and 
health problems related to migration 
and conﬂict. Authors should always send 
a pre-submission inquiry via our online 
journal management system (http://
medicine.plosjms.org/cgi-bin/main.
plex) so that we can assess the suitability 
of the topic ahead of formal submission. 
PLoS continues to receive requests 
to launch new journals. In this 
issue of PLoS Medicine, for example, 
Basia Zaba and colleagues make 
the case for a new open-access 
journal specializing in research on 
demographic surveillance—the process 
of monitoring births, deaths, causes of 
death, and migration in a population 
over time [14]. Our response to these 
requests is this: PLoS ONE (http://
www.plosone.org/) publishes any
study in science and medicine that is 
technically, scientiﬁcally, and ethically 
sound, subject to peer review, so there 
is now a home at PLoS for all original
biomedical research. Indeed PLoS ONE 
has already published research based 
on demographic health surveys, such 
as a study that used the 1998 South 
African Demographic and Health 
Survey to examine the association 
between measures of socioeconomic 
position and violence at the individual 
and household levels [15]. 
As PLoS continues to evolve, we 
plan to create “hubs” of linked open-
access content from across the PLoS 
journals to help serve speciﬁc research 
communities (see http://www.plos.
org/about/faq.html#ploshubs); our 
ﬁrst such hub is the PLoS Hub for 
Clinical Trials at http://clinicaltrials.
ploshubs.org/. We hope that these 
innovative new ways of presenting 
scientiﬁc research, from all corners 
of the globe and on topics that 
have traditionally been sidelined by 
subscription-based journals, will help 
take the “neglected” out of the term 
“neglected diseases.”  
Supporting Information 
Text S1. Articles published in the 
Neglected Diseases section from October 
2004–February 2008, focusing on tropical 
infections
Found at doi:10.1371/journal.
pmed.0050059.sd001 (30 KB DOC). 
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